Fondens formål er uden geografiske begrænsninger at yde enhver form for støtte til sygdomsbehandling og sygdomsbekæmpelse, herunder støtte til forskning med henblik på sygdomsbekæmpelse, og således at bekæmpelse af kræftsygdomme og hjernesygdomme tilgodeses i særligt omfang efter bestyrelsens nærmere skøn, at yde støtte til unges uddannelse, navnlig i form af rejse- og studielegater. Fordelingen mellem de nævnte formål er i øvrigt op til den til enhver tid værende fondsbestyrelses afgørelse.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 3.6 mio. | 8 mio. | 162.8 mio. | 141.3 mio. | 3 | |
CVR: 18164639
2 properties
Upgrade to Pro to see addresses, building data and ownership details
Compared to 567 companies in Støtteaktiviteter relateret til sygdomsbekæmpende, sociale og velgørende formål
Comparison is based on industry median values
Companies in the same industry and area
CVR 69978916
CVR 11658601
CVR 11609805
CVR 11627331
CVR 40386521
The financial health of IMK ALMENE FOND appears robust, with a significant profit increase from 5,850,514 DKK in 2023 to 7,980,803 DKK in 2024, alongside a steady revenue growth from 3,499,779 DKK to 3,578,473 DKK. After a challenging year in 2022, where the company reported a loss of 1,736,954 DKK, it has successfully returned to profitability, indicating effective management and operational improvements. The equity position is strong at 141,302,549 DKK, reflecting a solid foundation for future growth. Overall, the company is well-positioned within the support activities sector related to disease prevention and charitable purposes, showcasing resilience and potential for continued success.
AI-generated summary
companydata.dk